AE Wealth Management LLC lessened its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 51.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 742 shares of the medical equipment provider’s stock after selling 789 shares during the quarter. AE Wealth Management LLC’s holdings in Intuitive Surgical were worth $367,000 as of its most recent SEC filing.
Other hedge funds have also recently added to or reduced their stakes in the company. TFG Advisers LLC bought a new position in Intuitive Surgical during the 4th quarter worth about $25,000. Evolution Wealth Advisors LLC increased its holdings in Intuitive Surgical by 283.3% during the 4th quarter. Evolution Wealth Advisors LLC now owns 46 shares of the medical equipment provider’s stock worth $27,000 after purchasing an additional 34 shares in the last quarter. Virtus ETF Advisers LLC bought a new position in Intuitive Surgical during the 4th quarter worth about $31,000. Princeton Global Asset Management LLC bought a new position in Intuitive Surgical during the 4th quarter worth about $36,000. Finally, 1776 Wealth LLC increased its holdings in Intuitive Surgical by 72.2% during the 1st quarter. 1776 Wealth LLC now owns 62 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 26 shares in the last quarter. Hedge funds and other institutional investors own 85.09% of the company’s stock.
Shares of ISRG stock opened at $562.80 on Friday. The firm has a 50 day moving average price of $510.90 and a two-hundred day moving average price of $549.84. The company has a market capitalization of $63.67 billion, a PE ratio of 47.02, a price-to-earnings-growth ratio of 12.33 and a beta of 0.91. Intuitive Surgical, Inc. has a 12-month low of $360.50 and a 12-month high of $619.00.
Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, April 16th. The medical equipment provider reported $2.69 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.54 by $0.15. The firm had revenue of $1.10 billion during the quarter, compared to the consensus estimate of $1.01 billion. Intuitive Surgical had a net margin of 30.11% and a return on equity of 17.40%. The business’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same period last year, the business posted $2.61 earnings per share. Research analysts forecast that Intuitive Surgical, Inc. will post 6.78 earnings per share for the current fiscal year.
In other news, EVP Curet Myriam sold 3,000 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, April 22nd. The shares were sold at an average price of $503.76, for a total value of $1,511,280.00. Following the completion of the sale, the executive vice president now directly owns 3,816 shares in the company, valued at $1,922,348.16. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, SVP Jamie Samath sold 248 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, April 21st. The shares were sold at an average price of $506.18, for a total transaction of $125,532.64. Following the completion of the sale, the senior vice president now owns 385 shares of the company’s stock, valued at $194,879.30. The disclosure for this sale can be found here. Insiders have sold 14,034 shares of company stock valued at $7,381,613 over the last 90 days. Company insiders own 1.60% of the company’s stock.
A number of equities analysts have issued reports on ISRG shares. Raymond James lowered their target price on Intuitive Surgical from $660.00 to $600.00 and set an “outperform” rating for the company in a report on Monday, April 13th. Morgan Stanley decreased their price objective on Intuitive Surgical from $670.00 to $622.00 and set an “overweight” rating for the company in a report on Friday, March 27th. UBS Group decreased their price objective on Intuitive Surgical from $620.00 to $565.00 and set a “neutral” rating for the company in a report on Friday, April 17th. BTIG Research restated a “hold” rating on shares of Intuitive Surgical in a report on Friday, April 17th. Finally, Evercore ISI cut Intuitive Surgical from an “in-line” rating to an “underperform” rating in a report on Sunday, April 19th. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the stock. Intuitive Surgical currently has an average rating of “Hold” and a consensus price target of $572.50.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Featured Story: What is the return on assets formula?
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.